Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

McGill University

$27,000.00

Characterization of Mitochondrial Processing Peptidase Mutants Associated with Neurodegeneration

EF 2025-26

Résumé
Mitochondria are essential structures in cells that carry out key processes including cellular metabolism and energy production. Despite having their own DNA, most mitochondrial proteins are encoded in the nucleus and directed to mitochondria by a short region called the mitochondrial targeting sequence (MTS). Once in the mitochondria, MTSs are removed by the mitochondrial processing peptidase (MPP), an enzyme containing two subunits, MPPa and MPPB, each serving a distinct role. MPPa is responsible for recognition and binding of MTSs, while MPPB is responsible for cleaving MTSs. In humans, MPPa mutations cause movement disorders like ataxias, while MPPB mutations are more severe, leading to childhood neurodegeneration. The molecular basis of MPP-associated diseases is poorly studied and can have devastating consequences. This research aims to purify and characterize several patient-derived MPP mutations to uncover the molecular and structural impacts of these mutations on human MPP. To study these mutants, we will purify the proteins in bacteria using an optimized growth protocol previously developed in our lab. After purification, we will measure each mutant’s ability to form a dimer with its corresponding subunit, since dimerization is essential for MPP function. MTS cleavage activity will then be measured to determine whether the mutation impairs MPP’s ability to recognize and cleave MTSs. Finally, we will examine MPP’s substrate binding sites to determine whether these mutations cause conformational changes. This work will reveal how and why different MPP mutants cause ataxias and neurodegeneration. More importantly, understanding how these previously unstudied mutations disrupt MPP could help guide the development of new treatments for patients.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
573214
Name
Abraham Juliana M
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of Mitochondrial Processing Peptidase Mutants Associated with Neurodegeneration
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Ataxia; Mitochondria; Mitochondrial Processing Peptidase; Mitochondrial Quality Control; Mutation; Neurodegeneration
Abstract
Mitochondria are essential structures in cells that carry out key processes including cellular metabolism and energy production. Despite having their own DNA, most mitochondrial proteins are encoded in the nucleus and directed to mitochondria by a short region called the mitochondrial targeting sequence (MTS). Once in the mitochondria, MTSs are removed by the mitochondrial processing peptidase (MPP), an enzyme containing two subunits, MPPa and MPPB, each serving a distinct role. MPPa is responsible for recognition and binding of MTSs, while MPPB is responsible for cleaving MTSs. In humans, MPPa mutations cause movement disorders like ataxias, while MPPB mutations are more severe, leading to childhood neurodegeneration. The molecular basis of MPP-associated diseases is poorly studied and can have devastating consequences. This research aims to purify and characterize several patient-derived MPP mutations to uncover the molecular and structural impacts of these mutations on human MPP. To study these mutants, we will purify the proteins in bacteria using an optimized growth protocol previously developed in our lab. After purification, we will measure each mutant’s ability to form a dimer with its corresponding subunit, since dimerization is essential for MPP function. MTS cleavage activity will then be measured to determine whether the mutation impairs MPP’s ability to recognize and cleave MTSs. Finally, we will examine MPP’s substrate binding sites to determine whether these mutations cause conformational changes. This work will reveal how and why different MPP mutants cause ataxias and neurodegeneration. More importantly, understanding how these previously unstudied mutations disrupt MPP could help guide the development of new treatments for patients.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abraham, Juliana M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~